IMNN

Imunon, Inc. IMNN

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.5M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$753.8K total
ARMISTICE CAPITAL, LLC
$257.7K-58.4%
Riverview Capital Advisers, LLC
$247.8K0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$83.6K-2.3%
GEODE CAPITAL MANAGEMENT, LLC
$56.3K-4.8%
Virtu Financial LLC
$31.0KNew
VANGUARD FIDUCIARY TRUST CO
$23.6K0.0%
NORTHERN TRUST CORP
$18.4KNew
UBS Group AG
$9.3K+804.9%
BlackRock, Inc.
$7.9K0.0%
Tower Research Capital LLC (TRC)
$7.0K+111.8%
WELLS FARGO & COMPANY/MN
$5.9K0.0%
MORGAN STANLEY
$2.8K-48.1%
SBI Securities Co., Ltd.
$1.8K0.0%
BARCLAYS PLC
$345New
JPMORGAN CHASE & CO
$241New
Caitong International Asset Management Co., Ltd
$14New
GROUP ONE TRADING, L.P.
$110.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
$5New
OSAIC HOLDINGS, INC.
$30.0%
Steigerwald, Gordon & Koch Inc.
$20.0%
Game Plan Financial Advisors, LLC
$20.0%
FMR LLC
$20.0%
ROYAL BANK OF CANADA
$00.0%
See all 23 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/IMNN

Earnings Per Share

13fpro.ai/company/IMNN

Loading ratio trend…

IMNN key financials by period

Reported revenue, net income and operating margin by fiscal year, from Imunon, Inc.'s annual filings on SEC EDGAR.

Imunon, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2022$500.0K$-35.9M—
FY 2021$500.0K$-20.8M—
FY 2020$500.0K$-21.5M—
FY 2019$500.0K$-16.9M—
FY 2018$500.0K$-11.9M—
FY 2017$500.0K$-20.4M—
Source: IMNN filings on SEC EDGAR →

IMNN insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Imunon, Inc. (IMNN): stock profile, AI score and financials

Imunon, Inc. (IMNN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. IMNN is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.5m in revenue and is scored on the micro-cap board instead. Top institutional holders of IMNN by reported 13-F value include ARMISTICE CAPITAL, Riverview Capital Advisers, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. IMNN trades on the Nasdaq exchange and files with the SEC under CIK 749647. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IMNN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Imunon, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 749647 →